Reunion Neuroscience Alpha and Beta Analysis
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Reunion Neuroscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Reunion Neuroscience over a specified time horizon. Remember, high Reunion Neuroscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Reunion Neuroscience's market risk premium analysis include:
Beta (0.53) | Alpha 0.87 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Reunion |
Reunion Neuroscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Reunion Neuroscience market risk premium is the additional return an investor will receive from holding Reunion Neuroscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Reunion Neuroscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Reunion Neuroscience's performance over market.| α | 0.87 | β | -0.53 |
Reunion Neuroscience Fundamentals Vs Peers
Comparing Reunion Neuroscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Reunion Neuroscience's direct or indirect competition across all of the common fundamentals between Reunion Neuroscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Reunion Neuroscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Reunion Neuroscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Reunion Neuroscience to competition |
| Fundamentals | Reunion Neuroscience | Peer Average |
| Return On Equity | -0.86 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Current Valuation | (13.96 M) | 16.62 B |
| Shares Outstanding | 11.72 M | 571.82 M |
| Shares Owned By Insiders | 34.39 % | 10.09 % |
| Shares Owned By Institutions | 50.65 % | 39.21 % |
| Number Of Shares Shorted | 114.9 K | 4.71 M |
Reunion Neuroscience Opportunities
Reunion Neuroscience Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Reunion Neuroscience Announces 13.1M Take-Private Transaction With Biotech Investment Firm | 06/01/2023 |
2 | Whats Going On With Reunion Neuroscience Stock Today | 06/02/2023 |
3 | U.S. East Coast blanketed in eerie veil of smoke from Canada fires - Marketscreener.com | 06/07/2023 |
4 | Citing Food Allergy Incidents, Family Pulls Kids Out of VA Schools - Allergic Living | 06/16/2023 |
5 | The Class of 2023 Leaves With a Song In Their Heart - Scarsdale10583.com | 06/23/2023 |
6 | Stella acquires Field Trips U.S. assets to enhance its psychedelic therapy offerings - Mugglehead | 06/28/2023 |
7 | Field Trip Health Trading Down 2.3 | 07/05/2023 |
8 | Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement | 07/14/2023 |
About Reunion Neuroscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Reunion or other delisted stocks. Alpha measures the amount that position in Reunion Neuroscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Reunion Neuroscience Upcoming Company Events
As portrayed in its financial statements, the presentation of Reunion Neuroscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Reunion Neuroscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Reunion Neuroscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Reunion Neuroscience. Please utilize our Beneish M Score to check the likelihood of Reunion Neuroscience's management manipulating its earnings.
| 27th of September 2023 Upcoming Quarterly Report | View | |
| 13th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 26th of June 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Reunion Neuroscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Reunion Stock
If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |